Is a complete NVCT research report available?

No complete published report is available for Nuvectis Pharma, Inc. (NVCT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Nuvectis Pharma, Inc. (NVCT)

NASDAQ: NVCT · USD

$18.3

-0.18 (-1.0%)· Recorded snapshot

Market cap	594.9M
Net income (ttm)	-30.3M
EPS (ttm)	-$1.30
Shares out	32.6M
Volume	161,885
Beta	-0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -30.3M
EPS (ttm): -$1.30
Market cap: 594.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001875558
Company name	Nuvectis Pharma, Inc.
Country	United States
Country code	US
CUSIP number	67080T108
Earnings date	2026-11-10
Earnings time	bmo
Employees	16
Employees change	3
Employees growth	23.08%
Enterprise value	$572.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2022-02-04
Is primary listing	Yes
Is SPAC	No
ISIN number	US67080T1088
Last 10-K release date	2026-02-11
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$594.9M
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$18.26
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	NVCT
U.S. state	New Jersey
Website	https://www.nuvectis.com

Metric

Value

Amount currency

USD

CIK code

0001875558

Company name

Nuvectis Pharma, Inc.

Country

United States

Country code

CUSIP number

67080T108

Earnings date

2026-11-10

Earnings time

bmo

Employees

Employees change

Employees growth

23.08%

Enterprise value

$572.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2020

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2022-02-04

Is primary listing

Yes

Is SPAC

ISIN number

US67080T1088

Last 10-K release date

2026-02-11

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$594.9M

Market cap category

Small-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$18.26

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

NVCT

U.S. state

New Jersey

Website

https://www.nuvectis.com

Metric	Value
Earnings yield	-7.14%
FCF / EV yield	-3.41%
FCF yield	-3.28%
P/B ratio	54.2x
Price / tangible book value	65.4x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-7.14%

FCF / EV yield

-3.41%

FCF yield

-3.28%

P/B ratio

54.2x

Price / tangible book value

65.4x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-1.9M
ROA	-73.07%
ROCE	-317.86%
ROE	-214.58%
ROE (5Y)	-269.3%
ROIC	-139.03%

Metric

Value

Profit per employee

$-1.9M

ROA

-73.07%

ROCE

-317.86%

ROE

-214.58%

ROE (5Y)

-269.3%

ROIC

-139.03%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
EBIT	$-28.9M
EPS	$-1.30
FCF per share	$-0.60
Financing cash flow	$14.9M
Free cash flow	$-19.5M
Free cash flow minus SBC	$-26M
Net cash flow	$-4.6M
Net income	$-30.3M
Operating cash flow minus SBC	$-26M
Operating income	$-28.9M
Stock-based compensation	$6.5M

Metric

Value

EBIT

$-28.9M

EPS

$-1.30

FCF per share

$-0.60

Financing cash flow

$14.9M

Free cash flow

$-19.5M

Free cash flow minus SBC

$-26M

Net cash flow

$-4.6M

Net income

$-30.3M

Operating cash flow minus SBC

$-26M

Operating income

$-28.9M

Stock-based compensation

$6.5M

Metric	Value
Book value per share	$0.34
Debt / equity	0
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$22.2M
Net cash / market cap	3.73%
Net cash growth	-17.29%
Net debt / equity	-2.44
Piotroski F-Score	1
Shareholders' equity	$9.1M
Tangible book value	$9.1M
Tangible book value per share	$0.34
Total assets	$22.4M
Total cash	$22.2M
Total debt	$0
Total liabilities	$13.3M
WACC	2.92%

Metric

Value

Book value per share

$0.34

Debt / equity

Long-term assets

Long-term liabilities

Net cash (debt)

$22.2M

Net cash / market cap

3.73%

Net cash growth

-17.29%

Net debt / equity

-2.44

Piotroski F-Score

Shareholders' equity

$9.1M

Tangible book value

$9.1M

Tangible book value per share

$0.34

Total assets

$22.4M

Total cash

$22.2M

Total debt

Total liabilities

$13.3M

WACC

2.92%

Metric	Value
Current assets	$22.4M
Current liabilities	$13.3M
Current ratio	1.68
Net working capital	$-13.1M
Quick ratio	1.67
Working capital	$9.1M

Metric

Value

Current assets

$22.4M

Current liabilities

$13.3M

Current ratio

1.68

Net working capital

$-13.1M

Quick ratio

1.67

Working capital

$9.1M

Metric	Value
Buyback yield / dilution	-21.66%
Dividend yield	0%
Shareholder yield	-21.66%

Metric

Value

Buyback yield / dilution

-21.66%

Dividend yield

Shareholder yield

-21.66%

Metric	Value
150-day SMA	$16.46
1D price change	-0.98%
1M price change	-9.4%
1M total return	-9.4%
1W price change	-11.5%
1W total return	-11.5%
1Y price change	179.7%
1Y return CAGR	179.89%
1Y total return	179.7%
20-day SMA	$19.77
200-day SMA	$14.51
3M price change	-6.24%
3M total return	-6.24%
3Y price change	117.06%
3Y return CAGR	29.47%
3Y total return	117.06%
50-day SMA	$21.64
50-day SMA vs 200-day SMA	50over200
52-week high	$29.28
52-week high date	2026-06-29
52-week low	$5.55
52-week low date	2025-11-07
6M price change	109.37%
6M total return	109.37%
All-time high	$29.28
All-time high date	2026-06-29
All-time low	$3.08
All-time low date	2022-02-04
Average true range (ATR)	$1.45
Average volume	173.3K
Beta (1Y)	-0.99
Beta (2Y)	1.27
Beta (5Y)	-0.24
Change from 52-week high	-37.63%
Change from 52-week low	229.01%
Change from all-time high	-37.42%
Change from all-time low	494.81%
Change from open	-1.3%
Day's gap	0.33%
Dollar volume	$3M
High price	$18.70
Low price	$18.00
Monthly RSI	64.77
Open price	$18.50
Position in 52-week range	37.14%
Premarket change	1.41%
Premarket close	$18.44
Premarket price	$18.70
Previous close	$18.44
Price vs 150-day SMA	11.27%
Price vs 20-day SMA	-7.33%
Price vs 200-day SMA	26.25%
Price vs 50-day SMA	-15.34%
Relative volume	0.95
Return from IPO open	361.52%
Return from IPO price	264.6%
RSI	40.2
Sharpe ratio	1.59
Sharpe ratio (3Y)	0.67
Sortino ratio	2.66
Sortino ratio (3Y)	1.1
Volume	161.9K
Weekly RSI	51.13
YTD price change	142.65%
YTD total return	142.65%

Metric

Value

150-day SMA

$16.46

1D price change

-0.98%

1M price change

-9.4%

1M total return

-9.4%

1W price change

-11.5%

1W total return

-11.5%

1Y price change

179.7%

1Y return CAGR

179.89%

1Y total return

179.7%

20-day SMA

$19.77

200-day SMA

$14.51

3M price change

-6.24%

3M total return

-6.24%

3Y price change

117.06%

3Y return CAGR

29.47%

3Y total return

117.06%

50-day SMA

$21.64

50-day SMA vs 200-day SMA

50over200

52-week high

$29.28

52-week high date

2026-06-29

52-week low

$5.55

52-week low date

2025-11-07

6M price change

109.37%

6M total return

109.37%

All-time high

$29.28

All-time high date

2026-06-29

All-time low

$3.08

All-time low date

2022-02-04

Average true range (ATR)

$1.45

Average volume

173.3K

Beta (1Y)

-0.99

Beta (2Y)

1.27

Beta (5Y)

-0.24

Change from 52-week high

-37.63%

Change from 52-week low

229.01%

Change from all-time high

-37.42%

Change from all-time low

494.81%

Change from open

-1.3%

Day's gap

0.33%

Dollar volume

$3M

High price

$18.70

Low price

$18.00

Monthly RSI

64.77

Open price

$18.50

Position in 52-week range

37.14%

Premarket change

1.41%

Premarket close

$18.44

Premarket price

$18.70

Previous close

$18.44

Price vs 150-day SMA

11.27%

Price vs 20-day SMA

-7.33%

Price vs 200-day SMA

26.25%

Price vs 50-day SMA

-15.34%

Relative volume

0.95

Return from IPO open

361.52%

Return from IPO price

264.6%

RSI

40.2

Sharpe ratio

1.59

Sharpe ratio (3Y)

0.67

Sortino ratio

2.66

Sortino ratio (3Y)

1.1

Volume

161.9K

Weekly RSI

51.13

YTD price change

142.65%

YTD total return

142.65%

Metric	Value
Float	21.2M
Float percentage	65.08%
Shares change (QoQ)	0.26%
Shares change (YoY)	21.66%
Shares held by insiders	34.92%
Shares held by institutions	33.84%
Shares outstanding	32.6M
Short % of float	11.89%
Short % of shares	7.74%
Short ratio	12.3 days

Metric

Value

Float

21.2M

Float percentage

65.08%

Shares change (QoQ)

0.26%

Shares change (YoY)

21.66%

Shares held by insiders

34.92%

Shares held by institutions

33.84%

Shares outstanding

32.6M

Short % of float

11.89%

Short % of shares

7.74%

Short ratio

12.3 days

Nuvectis Pharma, Inc. (NVCT)

Price

Financial snapshot

Fair-value bridge

Latest news · NVCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NVCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NVCT

Frequently asked questions